Robert Masson is a neurosurgeon turned founder who runs eXeX (Expanded Existence), an AI and mixed-reality platform that captures surgical mastery and pipes holographic guidance into the sterile field. With more than three decades of spine surgery and 13,000-plus procedures behind him, he made global headlines for bringing the Apple Vision Pro into the operating room as a touch-free logistics tool. He is also the founder of the Masson Spine Institute and, at 52, raced to a podium at the Rolex 24 at Daytona alongside his eldest son.
Shafique Virani is a neurosurgeon-turned-biotech dealmaker who serves as Chief Business Officer of Noetik, an AI-native cancer therapeutics company in South San Francisco. He has spent two decades turning early-stage science into landmark partnerships, including one of the largest drug discovery deals ever struck at Recursion, and earlier built a neuroscience and rare-disease portfolio at Roche/Genentech that produced approved medicines like Risdiplam and Enspryng. At Noetik he is selling a new idea to pharma: not AI services, but licensable AI infrastructure for biology.
John R. Adler Jr., MD is a neurosurgeon, inventor, and serial entrepreneur best known for inventing the CyberKnife robotic radiosurgery system at Stanford University - a device that has treated over two million patients worldwide. Now CEO of ZAP Surgical Systems in San Carlos, California, he leads development of the ZAP-X gyroscopic radiosurgery platform: a self-shielded, vault-free system that brings precision brain radiosurgery to outpatient settings globally. A 2025 inductee into the National Inventors Hall of Fame, Adler is also co-founder and former editor-in-chief of Cureus, an open-access medical journal acquired by Springer Nature. With over 300 peer-reviewed publications and 20+ US patents, he holds the Dorothy and TK Chan Professorship Emeritus at Stanford.
Chris Mansi is a Cambridge and UCL-trained neurosurgeon turned AI entrepreneur, and the Co-founder and CEO of Viz.ai - the company that puts an AI brain between a CT scanner and a surgeon so that patients who are about to die of a stroke stop dying from delays. Named to TIME100 AI in 2024, Mansi built Viz.ai from a Stanford dorm-room insight into a platform covering nearly 2,000 U.S. hospitals and 230 million lives, reducing stroke diagnostic timelines by more than an hour - one patient at a time, every ten seconds.
Harpreet Mangat is a British-trained neurosurgeon turned Stanford MBA and McKinsey consultant who now serves as Chief Strategy Officer and Chief of Staff to the CEO at Hippocratic AI, a $3.5 billion healthcare AI company building clinically safe generative AI agents for patient engagement. His rare career arc - from brain surgery and ICU care during COVID-19, through venture capital and management consulting, to the frontier of healthcare AI - makes him one of the most credentialed operator-clinicians in the industry.